Optiver Holding
FLNA

Optiver Holding’s Filana Therapeutics FLNA Stock Holding History

Optiver Holding’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.82K Buy
+2,851
New +$5.87K ﹤0.01% 1440
2025
Q4 		– Sell
-12
Closed -$35 – 2924
2025
Q3 		$35 Buy
+12
New +$28 ﹤0.01% 2630

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Optiver Holding's FLNA Position: Q1 2026 in Review

Optiver Holding opened a new position in Filana Therapeutics (FLNA) in Q1 2026: 2,851 shares worth $4.82K. The stake represents ﹤0.01% of the portfolio and ranks #1440 among its holdings. This is a return to the name: Optiver Holding previously reported a position in FLNA as recently as Q3 2025.

Optiver Holding first reported a position in FLNA in Q3 2025 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Optiver Holding held 2,851 shares of Filana Therapeutics worth $4.82K as of Q1 2026.
  • Filana Therapeutics was a new Optiver Holding position in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1440 holding.
  • Optiver Holding first reported a position in Filana Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.